Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
about
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.Reasons for low quality of life in South Indian cancer patient population: a prospective observational study.Anthracycline cardiotoxicity: from bench to bedside.Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.Factors affecting quality of life in cancer patients undergoing chemotherapyQuality of Life in Cancer Patients undergoing Chemotherapy.Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials.Investigation the quality of life and its relation with clinical and demographic characteristics in women with breast cancer under chemotherapy.Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.Clinical relevance of single item quality of life indicators in cancer clinical trials.Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 BreaCognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Quality of life in women with recurrent breast cancer.Quality of life in breast cancer patients: a cluster analytic approach. Empirically derived subgroups of the EORTC-QLQ BR 23--a clinically oriented assessment.Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.Quality adjusted survival analysis with repeated quality of life measures.The impact of a second breast cancer diagnosis on health related quality of life.Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment.Quality of life of breast cancer survivors after a recurrence: a follow-up study.Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancer.The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.Effects of patient-centered communication on anxiety, negative affect, and trust in the physician in delivering a cancer diagnosis: A randomized, experimental study.Mental adjustment to first recurrence and correlated factors in patients with breast cancer.Profile and predictors of long-term morbidity in breast cancer survivors.Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors.Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery.Estimating the responsiveness of an instrument using more than two repeated measures.Chronomodulated chemotherapy: clinical value and possibilities for dissemination in the United States.Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff.Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population.Quality of life after adjuvant chemotherapy for breast cancer.Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial.
P2860
Q33217842-D4185E1E-4B29-4B36-884B-34B85C34C936Q33555321-110FD531-D598-4A03-9681-EA30B9263A9BQ34477415-3F98AFC6-2F96-4584-BE16-F59BFE63EB9FQ34818002-F3363392-0A3B-4113-A2BA-2A64ADF0DC13Q35171899-85BD7336-5D98-4365-AA33-749C01D93707Q35651518-05CD9574-AA85-49BF-A6D2-8EB98F22BF67Q35835151-4CAFC65A-99D5-4FA4-9DDE-20D6071C2758Q36115281-ED697FD3-2FE2-41C9-95F2-CAD7C156BF19Q36292207-B8D3A7C6-FB86-47B4-9E0C-7765B5BD553BQ36489045-9F268D91-D196-4DF3-B64A-5B9AF8138094Q36608806-DF433F65-1784-4C7C-9442-D75F0ADD3463Q36621853-3EDA508D-D82C-455E-95AB-9C18ED8C0FF4Q36622985-6928E24F-D8CE-4572-8D2C-EE5103026457Q36644559-4ADE8E61-3549-4893-B924-5D525AF63D2EQ36695170-06F670DB-E9C7-499F-8BA2-6EF5A001E2DEQ37367441-AC24D108-365C-4CFF-A18E-A65A603471C7Q37431101-322F4992-0A68-44ED-B489-6C77861BCDB7Q39263061-EE3EB3DF-ECE3-4DA5-9FEB-4D2B5ED776CEQ40679650-15FA5B81-2F76-4B14-838E-50BB932B472FQ43912882-57364937-6C36-41CA-93FD-C5AA01D251EFQ44026353-5625DDDE-167F-4468-84F3-7E966C3EF2CEQ44485665-CD865B73-0305-4961-BC69-76254EF01A71Q45023674-3B06C2BA-1AA3-4E46-B373-59BF93ED5CE3Q45260508-88AFFA83-E8F2-4F44-B078-37EE1A9A4976Q46101671-1A9B1464-76EC-43C2-8666-24957808D745Q46665709-6555D4E4-61EE-429B-B847-2CFDA3F25795Q46914108-BB542B66-1349-405B-8418-466F3218630DQ47330025-A185EA42-5E15-48D7-9F0D-2B581B05DEC1Q47346347-63DB318A-6BF2-4395-8782-091A27628707Q48237616-2DB3FBAC-673C-4E19-8446-9CA76AA56C3BQ48410722-EB154E1E-1C85-43D2-B6BE-339CDE18F436Q50992238-70357F0A-1136-4612-A308-CA845959ED2AQ51085261-CC1B20F2-5ECC-4911-89E2-94683F6F8427Q52927238-0CFB588E-9A74-40DE-B14B-23138B822178Q52938932-A8DAF003-6BE3-41FB-A442-D794A9D5EE8EQ53222910-76EB8D00-74E0-4C28-BF0E-5E7F39EBC8B0Q53510041-55CB11BF-1DE5-4EE7-A577-6841AD4AA8A3Q53511072-2564698F-BDE6-434E-B5CD-80F9AD2E49E7Q53560531-BA0F2A44-03BE-47BD-B582-2E0BD5FE0936
P2860
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Impact of adjuvant therapy on ...... nal Breast Cancer Study Group.
@en
type
label
Impact of adjuvant therapy on ...... nal Breast Cancer Study Group.
@en
prefLabel
Impact of adjuvant therapy on ...... nal Breast Cancer Study Group.
@en
P2093
P1433
P1476
Impact of adjuvant therapy on ...... nal Breast Cancer Study Group.
@en
P2093
A Goldhirsch
A S Coates
C M Rudenstam
D Crivellari
E Simoncini
H F Peterson
J Bernhard
J F Forbes
P304
P356
10.1016/S0140-6736(96)90936-8
P407
P577
1996-05-01T00:00:00Z